ArticleBMC neurology2026
Impact of balloon guiding catheter in contact aspiration thrombectomy using large bore aspiration catheter for acute anterior circulation stroke patients: a case-control study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of balloon guide catheter in endovascular treatment according to occlusion location.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBalloon guiding catheters (BGCs) have been shown to reduce distal embolization during mechanical thrombectomy with stent retrievers, but their benefit in contact aspiration thrombectomy (CAT) is not well established. We aimed to evaluate the impact of BGC use during CAT with large-bore aspiration catheters in acute anterior circulation large-vessel occlusion (LVO) stroke.
methodsWe retrospectively reviewed acute ischemic stroke patients with anterior circulation LVO treated with first-line CAT at two tertiary hospitals. Patients were grouped by whether a BGC was used. The predefined primary outcome was first-pass successful reperfusion, defined as achieving mTICI 2b–3 with a single thrombectomy device pass. Baseline characteristics, angiographic outcomes, and clinical outcomes were compared between groups. Subgroup analysis was performed for internal carotid artery (ICA)-involved versus isolated middle cerebral artery (MCA) occlusions.
resultsA total of 172 patients were included (101 with BGC, 71 without). The BGC group achieved a higher rate of complete reperfusion (mTICI 3: 60.4% vs. 47.9%, P = 0.047) and first-pass successful reperfusion (63.4% vs. 46.5%, P = 0.045) compared to the non-BGC group. BGC use was associated with shorter procedure time (median 51 vs. 65 min, P = 0.023) and less frequent need for device switching (26.7% vs. 46.5%, P = 0.007). At 3 months, favourable functional outcome (mRS 0–2) was more frequent with BGC (50.5% vs. 36.62%), although this difference did not reach statistical significance (P = 0.071). There were no significant differences in 90-day mortality or symptomatic intracranial hemorrhage between the groups. In patients with ICA-involving occlusions, BGC use yielded significantly higher rates of favorable outcome (50.8% vs. 30.0%, P = 0.030) and first-pass complete reperfusion (59.3% vs. 30.0%, P = 0.010) compared to no BGC. In contrast, outcomes in MCA-only occlusions were similar with or without BGC.
conclusionsThe use of a BGC during CAT for anterior circulation stroke was associated with improved reperfusion success and more efficient procedures. BGCs may enhance first-pass recanalization and possibly functional outcomes, particularly in ICA terminus occlusions, without increasing adverse events. These findings support the incorporation of BGCs as a valuable adjunct to CAT in appropriate patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.